Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider, has voluntarily assigned an ESG rating of 73 (Excellent) for the year 2025 as part of its ESG assessment process.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited has been assigned an ESG score of 73, rated as 'Excellent', for the year 2025 by ESG Risk Assessments & Insights Limited, a SEBI-registered ESG rating provider. The rating was done on a voluntary basis by the rating agency, and Wockhardt clarified that it had not engaged or commissioned the agency for this exercise. The score was determined independently by the agency using the company's publicly available disclosures and other public information. The filing was made under SEBI's listing obligations disclosure rules.
A high ESG rating of 73 (Excellent) from a SEBI-registered provider is a positive reputational signal and may appeal to ESG-focused institutional investors, though it was not solicited by the company. The market impact is likely modest since this is an independently assigned rating without any operational or financial implication.